tiprankstipranks
Solventum Corporation (SOLV)
NYSE:SOLV
US Market
Want to see SOLV full AI Analyst Report?

Solventum Corporation (SOLV) Blogger Opinions & Sentiment

300 Followers

Blogger Sentiment

Bullish: 80.00%
Sector Average
Bullish
SOLV Blogger sentiment is based on 6 Blogger Opinions. The Blogger sentiment is more Bullish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
60% SeekingAlpha
20% Investing
20% Zacks
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Not enough top blogger opinions at this time
Please return soon. This page is being updated.
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

Top insider buys and sells disclosed on Friday
Investing
Solventum stock up as Q2 earnings, revenues beat estimates
Zacks
Solventum: A Solid Performance Here
SeekingAlpha
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any

FAQ

What do Seeking Alpha bloggers think of SOLV?
Seeking Alpha’s The Alpha Sieve has a Neutral Sentiment.
    What do Motley Fool contributors think of SOLV?
    Currently there's no blogger sentiment for SOLV.
    What Is SOLV’s Blogger Sentiment?
    SOLV’s Blogger Sentiment is Bullish.
      What was the most recent blogger prediction for SOLV?
      The most recent blogger prediction for SOLV was made by Solventum Corp, who was Neutral on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          CADLCandel Therapeutics
          MLTXMoonLake Immunotherapeutics
          DFTXDefinium Therapeutics
          TGTXTG Therapeutics
          PGENPrecigen